Health-Related Quality of Life With Trastuzumab Monotherapy Versus Trastuzumab Plus Standard Chemotherapy as Adjuvant Therapy in Older Patients With HER2-Positive Breast Cancer

Medicine & Life Sciences

• Adjuvant Chemotherapy 82%
• Anxiety 19%
• Breast Neoplasms 52%
• Depression 17%
• Drug Therapy 15%
• Geriatrics 51%
• human ERBB2 protein 100%
• Mental Competency 26%
• Morale 57%
• Neoplasms 13%
• Peripheral Nervous System Diseases 14%
• Quality of Life 52%
• Therapeutics 13%
• Tokyo 32%
• Trastuzumab 96%